3-(4-chlorophenyl)-N-methyl-N'-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine,
SLV 319,
SLV-319,
SLV319,
362519-49-1,
(+/-)-SLV 319,
( inverted exclamation markA)-SLV319,
CHEMBL158784,
( inverted exclamation markA)-Ibipinabant,
SLV319,
SLV-319,
C23H20Cl2N4O2S,
(S)-SLV 319,
( inverted exclamation markA)-SLV 319,
RAC-IBIPINABANT,
R-SLV319,
SCHEMBL1315229,
SCHEMBL14740149,
BDBM29094,
CTK8E8422,
DTXSID60457819,
rac-(+/-)-SLV 319,
HMS3650M14,
1056AH,
BDBM50230411,
HY-14791A,
AKOS024458248,
CS-6430,
( inverted exclamation markA)-BMS6462,
( inverted exclamation markA)-SLV-319,
(R)-(+)-SLV 319,
( )-SLV 319,
(+/-)-SLV319,
AK555637,
RT-015587,
SR-01000946306,
SR-01000946306-1,
( inverted exclamation markA)-Ibipinabant;( inverted exclamation markA)-BMS646256,
(R)-(+)-3-(4-chlorophenyl)-N'-(4-chlorophenylsulfonyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide,
(S)-3-(4-chlorophenyl)-N-(4-chlorophenylsulfonyl)-N'-methyl-4-phenyl-4,5-dihydropyrazole-1-carboxamidine,
3-(4-chlorophenyl)-N''''''''-(4-chlorophenylsulfonyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide,
3-(4-chlorophenyl)-N'-(4-chlorophenylsulfonyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide,
3-(4-Chlorophenyl)-N-[(4-Chlorophenyl)sulfonyl]-4,5-dihydro-N'-methyl-4-phenyl-1H-pyrazole-1-carboximidamide,
4-Chloro-N-[1-[3-(4-chloro-phenyl)-4-phenyl-4,5-dihydro-pyrazol-1-yl]-1-methylamino-meth-(E)-ylidene]-benzenesulfonamide,
Ibipinabant,
((plusmn))-SLV319,
CID 9826744,
CID11179267,
464213-10-3,
656827-86-0,